Indeed, TNF-α can exacerbate T1D and EAE when administered early during disease initiation and can inhibit disease progression when administered at later time points (Ruddle et al., 1990; Willenborg et al., 1995; Wu et al., 2002). This evidence concerns the gene TNF and type 1 diabetes mellitus.